Delivery Order SPE2DB20D3303-SPE2DB25FA1ZD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,112.98 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count package). This is a firm fixed price contract with an ultimate completion date of September 12, 2025, and was awarded on September 11, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) with a contract value of $28,842.31. This competitively awarded, firm fixed-price delivery order is classified as non-set-aside and is scheduled for completion by August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Abiroterone Acetate 250 mg tablets (120-count supply) on September 15, 2025, with a ceiling value of $1,539.02. This competitive, firm fixed-price delivery order is scheduled for ultimate completion by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,023.83 on July 28, 2025, for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 29, 2025, and fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Abiroterone Acetate is a hormone therapy medication commonly used in cancer treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $31,517.29 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This competitive, firm fixed-price contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $1,745.56 delivery order to AmerisourceBergen Drug Corp for Abiraterone Acetate 250 mg tablets (120-count supply) under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside order represents a competitive award to support federal medical procurement needs, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.06 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60 count) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical products will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,307.40 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120 count). This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 18, 2025. The contract carries no set-aside designation, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. Abiroterone Acetate is an androgen...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1ZDDelivery Order
The Defense Logistics Agency awarded a $1,835.88 delivery order to AmerisourceBergen Drug Corp for Abiroterone Acetate 250 mg tablets (30-count unit dose packaging) with a completion date of July 31, 2025. This competitive award, issued on July 30, 2025, represents a firm fixed price delivery against AmerisourceBergen's larger indefinite delivery contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. No set-aside designation was applied to this procurement. This delivery order is executed under AmerisourceBergen's SPE2DX Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military and federal healthcare systems worldwide. Abiroterone acetate, an oral prostate cancer medication, reflects the specialized pharmaceutical commodities supported through this prime vendor agreement, which facilitates medical supply chain operations for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/30/25 |